Cas:1795-27-3 1,cis-3,cis-5-Trimethylcyclohexane manufacturer & supplier

Chemical Name:1,cis-3,cis-5-Trimethylcyclohexane

CAS.NO:1795-27-3

Synonyms:1,3,5-Trimethylcyclohexane,cis,cis;1,3,5-cis-Trimethylcyclohexane;all-cis-1,3,5-trimethylcyclohexane;cis,cis-1,3,5-trimethylcyclohexane;cis-1,3,5-trimethyl-cyclohexane;1r,3c,5c-trimethylcyclohexane;CIS,CIS,CIS-1,3,5-TRIMETHYLCYCLOHEXANE;Cyclohexane,1,3,5-trimethyl-,cis;r-1,c-3,c-5-trimethylcyclohexane;csi-1,3,5-trimethylcyclohexane;c,c,c-1,3,5-TRI METHYLCYCLOHEXANE;1-cis-3-cis-5-trimethylcyclohexane

Molecular Formula:C₉H₁₈

Molecular Weight:126.23900

HS Code:2902199090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:139.499ºC at 760 mmHg

Density:0.759g/cm3

Index of Refraction:1.416

PSA:

Exact Mass:126.14100

LogP:3.07860

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1,3,5-Trimethylcyclohexane,cis,cis chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-cis-3-cis-5-trimethylcyclohexane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,cis,cis-1,3,5-trimethylcyclohexane Use and application,1,3,5-cis-Trimethylcyclohexane technical grade,usp/ep/jp grade.

Related News: The Darzalex-Rd regimen got its FDA go-ahead in transplant-ineligible patients in 2019 based on data from the same phase 3 MAIA trial showing it could pare down the risk of disease progression or death by 44% after a median follow-up of 28 months. Now, after 56.2 months of follow-up, over half of Darzalex patients were still alive without their disease worsening, a showing that’s again “unprecedented” for a front-line myeloma treatment, Tendler said. 1,cis-3,cis-5-Trimethylcyclohexane manufacturer Subsequently, the company launched the drug under the brand names ‘Remo’ and ‘Remozen’. 1,cis-3,cis-5-Trimethylcyclohexane supplier Defense Secretary Mark Esper has approved a request to provide military housing for up to 1,000 people who may need to be quarantined after arriving in the US from overseas travel, the Pentagon said in a statement. 1,cis-3,cis-5-Trimethylcyclohexane vendor The Darzalex-Rd regimen got its FDA go-ahead in transplant-ineligible patients in 2019 based on data from the same phase 3 MAIA trial showing it could pare down the risk of disease progression or death by 44% after a median follow-up of 28 months. Now, after 56.2 months of follow-up, over half of Darzalex patients were still alive without their disease worsening, a showing that’s again “unprecedented” for a front-line myeloma treatment, Tendler said. 1,cis-3,cis-5-Trimethylcyclohexane factory Subsequently, the company launched the drug under the brand names ‘Remo’ and ‘Remozen’.